首页> 外文OA文献 >Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis.
【2h】

Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis.

机译:子宫内膜异位症妇女子宫内膜中单核细胞趋化蛋白1的表达增加。

摘要

The pathogenesis of endometriosis, a disease widely believed to arise from an aberrant growth of endometrial tissue outside the uterus, is still unclear. We have previously observed that cytokine-stimulated endometrial cells of women with endometriosis secrete in vitro increased amounts of monocyte chemotactic protein-1 (MCP-1). This factor may be important in the recruitment and activation of peritoneal macrophages observed in endometriosis patients. The present study reports that, in the presence of the disease, such an up-regulation of MCP-1 expression arises in vivo and can be encountered in situ in the intrauterine endometrium. In women with endometriosis, MCP-1 expression was elevated in endometrial glands, both at the level of the protein (immunohistochemistry) and the mRNA (in situ hybridization). This was observed throughout the menstrual cycle and varied according to the stage of the disease. These findings strongly argue in favor of the presence of pathophysiological changes in the eutopic endometrium of patients with endometriosis and make plausible MCP-1 as a key effector cell mediator involved in the pathogenesis of the disease.
机译:子宫内膜异位症的发病机理尚不清楚,该病广泛被认为是由子宫外子宫内膜组织异常生长引起的。我们以前曾观察到子宫内膜异位症妇女的细胞因子刺激的子宫内膜细胞在体外分泌增加的单核细胞趋化蛋白1(MCP-1)数量。在子宫内膜异位症患者中观察到的腹膜巨噬细胞的募集和激活中,这一因素可能很重要。本研究报告说,在该疾病的存在下,MCP-1表达的这种上调在体内出现,并且可以在子宫内膜内原位遇到。在患有子宫内膜异位症的女性中,子宫内膜腺体中的MCP-1表达升高,无论是蛋白质水平(免疫组织化学)还是mRNA水平(原位杂交)。在整个月经周期都观察到了这一现象,并且根据疾病的阶段而有所不同。这些发现强烈支持子宫内膜异位症患者在位子宫内膜的病理生理学改变,并使合理的MCP-1作为参与该疾病发病机制的关键效应细胞介体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号